Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 7.02% |
AMGEN INC. | AMGN | 4.85% |
GILEAD SCIENCES, INC. | GILD | 4.69% |
VERTEX PHARMACEUTICALS | VRTX | 4.07% |
CORTEVA INC | CTVA | 3.65% |
ALNYLAM PHARMACEUTICALS | ALNY | 3.21% |
REGENERON PHARMACEUTICALS | REGN | 3.06% |
BEONE MEDICINES LTD-ADR | BGNE | 2.46% |
NATERA INC | NTRA | 2.33% |
ASTRAZENECA PLC ADR | AZN | 2.24% |
INSMED INC | INSM | 2.20% |
ROYALTY PHARMA PLC- CL A | RPRX | 2.02% |
BIOGEN IDEC, INC. | BIIB | 1.99% |
ILLUMINA INC | ILMN | 1.77% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.74% |
EXACT SCIENCES | EXAS | 1.70% |
EXELIXIS, INC. | EXEL | 1.65% |
UNITED THERAPEUTICS CORP | UTHR | 1.63% |
BLUEPRINT MEDICI | BPMC | 1.59% |
INCYTE CORP | INCY | 1.54% |
VIATRIS INC | VTRS | 1.53% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.37% |
ARGENX SE - ADR | ARGX | 1.32% |
BRIDGEBIO PHARMA INC | BBIO | 1.31% |
GUARDANT HEALTH INC | GH | 1.28% |
REVOLUTION MEDICINES INC | RVMD | 1.27% |
BIONTECH SE-ADR | BNTX | 1.26% |
MODERNA INC | MRNA | 1.25% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.23% |
HALOZYME THERAPEUTICS INC | HALO | 1.13% |
IONIS PHARMACEUTICALS, IN | IONS | 1.13% |
ALKERMES PLC | ALKS | 1.11% |
ADMA BIOLOGICS INC | ADMA | 1.09% |
CRISPR THERAPEUTICS AG | CRSP | 1.08% |
ROIVANT SCIENCES LTD | ROIV | 1.08% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.05% |
TG THERAPEUTICS | TGTX | 1.05% |
MEDPACE HOLDINGS | MEDP | 0.99% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.87% |
ULTRAGENYX PHARM | RARE | 0.86% |
PROTAGONIST THER | PTGX | 0.86% |
AVIDITY BIOSCIENCES INC | RNA | 0.85% |
AXSOME THERAPEUT | AXSM | 0.85% |
SPRINGWORKS THERAPEUTICS | SWTX | 0.83% |
PTC THERAPEUTICS | PTCT | 0.81% |
CYTOKINETICS INC | CYTK | 0.80% |
VIKING THERAPEUTICS INC | VKTX | 0.79% |
CRINETICS PHARMACEUTICALS | CRNX | 0.75% |
SUMMIT THERAPEUTICS INC | SMMT | 0.70% |
ASCENDIS PHA-ADR | ASND | 0.70% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.69% |
ARCELLX INC | ACLX | 0.69% |
IDEAYA BIOSCIENCES INC | IDYA | 0.69% |
VAXCYTE INC | PCVX | 0.66% |
AGIOS PHARMACEUT | AGIO | 0.65% |
DENALI THERAPEUT | DNLI | 0.63% |
NUVALENT INC-A | NUVL | 0.63% |
VERACYTE INC | VCYT | 0.62% |
RECURSION PHARMACEUTICALS | RXRX | 0.61% |
DYNE THERAPEUTICS INC | DYN | 0.60% |
APELLIS PHARMACE | APLS | 0.59% |
TWIST BIOSCIENCE CORP | TWST | 0.56% |
SAREPTA THERAPEU | SRPT | 0.53% |
AMICUS THERAPEUTICS INC | FOLD | 0.53% |
CELLDEX THERAPEUTICS INC | CLDX | 0.51% |
MADRIGAL PHARMAC | MDGL | 0.51% |
BEAM THERAPEUTICS INC | BEAM | 0.51% |
NOVAVAX INC | NVAX | 0.46% |
DYNAVAX TECHNOLOGY | DVAX | 0.46% |
IMMUNOVANT INC | IMVT | 0.45% |
KRYSTAL BIOTECH INC | KRYS | 0.41% |
INTELLIA THERAPE | NTLA | 0.40% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.32% |
GERON CORP | GERN | 0.29% |
Other (Cash, derivatives and other liabilities) | 0.39% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.